Danaher Corporation (BMV:DHR)
Mexico · Delayed Price · Currency is MXN | Market Cap | 2.20T -13.4% |
| Revenue (ttm) | 438.04B +4.6% |
| Net Income | 69.86B +17.3% |
| EPS | 98.31 +19.6% |
| Shares Out | n/a |
| PE Ratio | 31.55 |
| Forward PE | 20.12 |
| Dividend | 25.78 (0.85%) |
| Ex-Dividend Date | Jun 26, 2026 |
| Volume | 2,066 |
| Open | 3,028.00 |
| Previous Close | 3,525.28 |
| Day's Range | 3,018.00 - 3,080.97 |
| 52-Week Range | 2,795.00 - 4,273.97 |
| Beta | 0.82 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 21, 2026 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufact... [Read more]
Financial Performance
In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.
Financial numbers in USD Financial StatementsNews
Danaher Stock (DHR) Is Down 13% and Suffering Its Worst Decline in 30 Years. Here’s Why
The company makes medical diagnostic equipment.
Bio-Rad slips as Sartorius weighed on by Danaher bioprocessing unit miss
Sartorius (SSSGY) shares are trading lower in Europe after earnings from competitor Danaher (DHR), including bioprocessing unit results that missed expectations. Bio-Rad Laboratories (BIO), which owns...
Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise
Danaher raised its annual profit forecast on Tuesday, but shares fell nearly 12% in premarket trading after the life sciences firm trimmed its core revenue growth outlook and reported weaker-than-exp...
Danaher Earnings Call Transcript: Q2 2026
Q2 2026 delivered better-than-expected revenue, earnings, and cash flow, with strong life sciences and diagnostics performance. Raised full-year guidance for core revenue growth and adjusted EPS, supported by robust order trends, innovation, and successful M&A activity.
Danaher Quarterly report: Q2 2026
Danaher has published its Q2 2026 quarterly earnings report on July 21, 2026.
Danaher Earnings release: Q2 2026
Danaher released its Q2 2026 earnings on July 21, 2026, summarizing the period's financial results.
Danaher Slides: Q2 2026
Danaher has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 21, 2026.
Danaher reports Q2 adjusted EPS $1.94, consensus $1.84
Reports Q2 revenue $6.27B, consensus $6.14B. Rainer M. Blair, President and Chief Executive Officer, stated, “We delivered a better than expected second quarter, with core growth improving versus the ...
Danaher sees Q3 non-GAAP core revenue up 2%-3% y/y
06:01 EDT Danaher (DHR) sees Q3 non-GAAP core revenue up 2%-3% y/y
Danaher sees FY26 non-GAAP core revenue up 3%-4% y/y
06:01 EDT Danaher (DHR) sees FY26 non-GAAP core revenue up 3%-4% y/y
Danaher raises FY26 adjusted EPS view to $8.45-$8.60 from $8.35-$8.55
Consensus is $8.50.
Danaher Reports Second Quarter 2026 Results
WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period...
Danaher price target lowered to $230 from $232 at Evercore ISI
Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Danaher (DHR) to $230 from $232 and keeps an Outperform rating on the shares. The firm’s Q2 preview for…
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the...
The Big 3: JPM, DHR, MRK
Dan Deming talks joins today's Big 3 and highlights JPMorgan Chase (JPM) as shares touch new record highs. He sees Danaher (DHR) as a candidate for a continuing breakout, noting a similar pattern in M...
Danaher Schedules Second Quarter 2026 Earnings Conference Call
WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 be...
Danaher’s Masimo receives FDA 510k clearance for OIRD detection on Radius VSM
Masimo, a Danaher (DHR) company, announced FDA 510(k) clearance for an opioid-induced respiratory depression, OIRD, detection capability integrated into the Radius VSM wearable continuous patient moni...
Danaher initiated with a Neutral at Piper Sandler
Piper Sandler initiated coverage of Danaher (DHR) with a Neutral rating and $200 price target The firm launched coverage of the life science tools sector with a “feet in the…
Danaher completes acquisition of Masimo
Danaher (DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo (MASI). Masimo’s trusted brand, advanced sensor technology and AI-enabled pati...
Danaher Completes Acquisition of Masimo Corporation
WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a lea...
Sirius XM Holdings Set to Join S&P MidCap 400
NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11....